Professor of Medicine, University Pittsburgh
Endocrinology
Dr. Susan L. Greenspan, MD
|
|
Give Review
Susan L. Greenspan is an expert in the field of Endocrinology. She went to medical school at Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1 in research and 12 in primary care medicine She has 3 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Pittsburgh Magazine". Susan L. Greenspan is also published. She has 71 publications published. The lastest publication: "Estimations of Dietary Vitamin D Requirements in Black and White Children.' She accepts all Medicare patients.
Publications
- Estimations of Dietary Vitamin D Requirements in Black and White Children.
- Erratum to: Odanacatib for the treatment of postmenopausal Osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacat...
- Dosing Strategies of Bone-Targeting Agents-Reply.
- Prevention of bone loss with risedronate in breast Cancer survivors: a randomized, controlled clinical trial.
- Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for Osteoporosis or low bone density.
- Odanacatib for the treatment of postmenopausal Osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture ...
- International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.
- A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study of the Calcium-Sensing Receptor Antagonist MK-5442 in the Treatment of Postmenopausal Women With Osteopor...
- Assessing the Effects of Teriparatide Treatment on Bone Mineral Density, Bone Microarchitecture, and Bone Strength.
- Empirically Based Composite Fracture Prediction Model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).
- Associations Between Bone Mineral Density, Grip Strength, and Lead Body Burden in Older Men.
- Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review.
- A Clinician Performance Initiative to Improve Quality of Care for Patients with Osteoporosis.
- Impact of Seasonal Flux on 25-hydroxyVitamin D and Bone Turnover in Pre- and Early Pubertal Youth.
- A comparison of DXA and CT based methods for estimating the strength of the femoral neck in post-menopausal women.
- Ethnic variability in bone geometry as assessed by hip structure analysis: findings from the hip strength across the menopausal transition study.
- Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with Osteoporosis.
- Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of Osteoporosis in women.
- COMPETITIVE ATHLETIC PARTICIPATION, THIGH MUSCLE STRENGTH, AND BONE DENSITY IN ELITE SENIOR ATHLETES AND CONTROLS.
- Vertebral fractures and trabecular microstructure in men with prostate Cancer on androgen deprivation therapy.
- Predictors Of The Effects Of 4 Years Of Growth Hormone Replacement On Bone Mineral Density In Patients With Adult-Onset Growth Hormone Deficiency - A Kims Database Ana...
- Response to shil and greer.
- Impact of generic alendronate cost on the cost-effectiveness of Osteoporosis screening and treatment.
- Cost-effectiveness of different screening strategies for Osteoporosis in postmenopausal women.
- Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of Osteoporosis in women.
- Predicting fractures in an international cohort using risk factor algorithms, without bone mineral density.
- Vertebral Fractures and the Misclassification of Osteoporosis in Men With Prostate Cancer.
- Impact of season and diet on Vitamin d status of african american and caucasian children.
- Regional differences in treatment for Osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).
- Unreplaced sex steroid Deficiency, corticotropin Deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone Deficiency: a...
- Radiographic Emphysema Predicts Low Bone Mineral Density in a Tobacco-exposed Cohort.
- Height loss, vertebral fractures, and the misclassification of Osteoporosis.
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal Osteoporosis: executive su...
- Health Beliefs about Osteoporosis and Osteoporosis Screening in Older Women and Men.
- Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy.
- Thigh muscle strength in senior athletes and healthy controls.
- Osteoporosis screening preferences of older adults.
- Factors associated with Osteoporosis screening and recommendations for Osteoporosis screening in older adults.
- Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.
- Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element an...
- Early responsiveness of women with Osteoporosis to teriparatide after therapy with alendronate or risedronate.
- Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate Cancer undergoing androgen-deprivation therapy.
- Effects of PTH and alendronate on Type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study.
- Risedronate prevents bone loss in breast Cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial.
- Physical function changes in prostate Cancer patients on androgen deprivation therapy: a 2-year prospective study.
- Approach to the prostate Cancer patient with bone disease.
- Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children.
- Physical function in men with prostate Cancer on androgen deprivation therapy.
- SOLAR ultraviolet radiation and Vitamin D: a historical perspective.
- Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate Cancer: a randomized trial.
- Elevations in serum and urinary Calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis.
- The effect of androgen deprivation therapy on periodontal disease in men with prostate Cancer.
- Prevention of bone loss in survivors of breast Cancer: A randomized, double-blind, placebo-controlled clinical trial.
- Bisphosphonates and osteonecrosis of the jaw.
- A pilot study of heel ultrasound to screen for low bone mass in children with leukemia.
- Quality of life in prostate Cancer patients taking androgen deprivation therapy.
- Bone loss after initiation of androgen deprivation therapy in patients with prostate Cancer.
- The effect of hormone replacement on physical performance in community-dwelling elderly women.
- Vitamin D insufficiency in preadolescent African-American children.
- Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial.
- Vitamin D supplementation in older women.
- Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacemen...
- Skeletal integrity in patients with nail patella syndrome.
- Altered bone mass in children at diagnosis of Crohn disease: a pilot study.
- Gastric bypass surgery for morbid Obesity leads to an increase in bone turnover and a decrease in bone mass.
- Vignettes in Osteoporosis: a road map to successful therapeutics.
- Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.
- Does bone mineral density and knowledge influence health-related behaviors of elderly men at risk for Osteoporosis?
- Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteopo...
- Alendronate improves bone mineral density in elderly women with Osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial.
Schools
HARVARD MED SCH
Conditions Treated
- Calcium Metabolism Disorders
- Diabetes Type 2
- Goiter
- Hypercalcemia
- View All
Doctors Specialties
- Geriatric Medicine
- Endocrinology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Pittsburgh Magazine
Education
-
Massachusetts General Hospital -
Beth Israel Deaconess Medical Center -
Harvard Medical School
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1174596076 | |
| NPPES Provider LastName | GREENSPAN | |
| NPPES Provider FirstName | SUSAN | |
| NPPES Provider ZIPCode | 152133215 | |
| NPPES Provider State | PA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 202.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174596076 |
| Last Name Of The Provider | GREENSPAN |
| First Name Of The Provider | SUSAN |
| View All |
Similar Doctors
|
|
Dr. Michael C. Dresser, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gijsberta J. Van Londen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas P. Wein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heather L. McQuillan, DO |
|
|
Dr. Chester B. Good, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gordon L. Handelsman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arshad I. Chughtai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James J. Reilly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thaddeus A. Osial Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jodie A. Reider, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shane O. Lebeau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle L. Griffith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luigi R. Garibaldi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet A. Amico, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|